Sugammadex
Trade names | Bridion |
---|---|
![]() | |
Clinical data | |
Uses | Reversal of neuromuscular blockade from rocuronium and vecuronium |
Contraindications | Renal impairment |
Routes of administration | Intravenous |
Dosage | Based upon response to train-of-four stimulation:
|
Pharmacodynamics | |
Mechanism of action | Encapsulation of rocuronium or vecuronium |
Adverse effects | Bradycardia, may interfere with hormonal contraceptives |
Pharmacokinetics | |
Physical and chemical data | |
Formula | C72H112O48S8 |
Molar mass | 2002.12 g/mol |
Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium.
Uses
If a patient requires reparaylsis after administration of sugammadex (up to 4 mg/kg), rocuronium or vecuronium can be re-administered after a minimum waiting time.[1]
Drug and dose to be administered | Minimum waiting time |
---|---|
Rocuronium 1.2 mg/kg | 5 minutes |
Rocuronium 0.6 mg/kg or
vecuronium 0.1 mg/kg |
4 hours |
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel